Oral Anti-Diabetes Drugs Market 2027 by Dosage type, Drug class, Distribution channel | The Insight Partners

Oral Anti-Diabetes Drugs Market to 2027 - Global Analysis and Forecasts by Dosage type ( Liquid, Capsule, Tablet ); Drug class ( Sulfonylureas, Meglitinides, Biguanides, Others ); Distribution channel ( Hospital Pharmacies, Retail Pharmacies, Online Pharmacies )

Report Code: TIPRE00007627 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Diabetics is also called high blood sugar. Insulin is a hormone that regulates the blood sugar level in the body. Drugs used in diabetes treat diabetes mellitus by lowering the glucose level in the blood. There are different classes of anti-diabetic drugs, and their selection depends on the nature of diabetes, age, and situation of the person, as well as other factors.

MARKET DYNAMICS

The oral anti-diabetes drugs market is anticipated to grow in the market by increasing in population and changing lifestyle are the factors projected to drive the market growth. Also, advancements in technologies and reimbursement for medicines are anticipated to fuel the growth of the oral anti-diabetes drug market. Moreover, rising incidence of diabetes is expected to increase demand for oral anti-diabetes drugs. However, ongoing research on diabetic treatment and high market potential are expected to create opportunities in the oral anti-diabetes market in the forecast period.

MARKET SCOPE

The "Oral Anti-Diabetes Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of in oral anti-diabetes drugs market with detailed market segmentation by dosage type, drug class, distribution channel and geography. The oral anti-diabetes drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in oral anti-diabetes drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The oral anti-diabetes drugs market is segmented on the basis of dosage type, drug class and distribution channel. Based on dosage type the market is segmented as liquid, capsule and tablet. On the basis of drug class the market is categorized as sulfonylureas, meglitinides, biguanides and others. On the basis of distribution channel the market is categorized as hospital pharmacies, retail pharmacies and online pharmacies.



Get more information on this report :

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in oral anti-diabetes drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The oral anti-diabetes drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting oral anti-diabetes drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the oral anti-diabetes drugs market in these regions.



Get more information on this report :

MARKET PLAYERS

The report covers key developments in the in oral anti-diabetes drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in oral anti-diabetes drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for in oral anti-diabetes drugs market in the global market. Below mentioned is the list of few companies engaged in the Oral Anti-Diabetes Drugs market.

The report also includes the profiles of key in oral anti-diabetes drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Abbott
  •  Biocon
  •  Eli Lilly and Company
  •  GlaxoSmithKline plc.
  •  Merck & Co., Inc.
  •  Novartis AG
  •  Novo Nordisk A/S
  •  Piramal Enterprises Ltd.
  •  Sanofi
  •  Sun Pharmaceutical Industries Ltd.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Oral Anti-Diabetes Drugs Market - By Dosage type
1.3.2 Oral Anti-Diabetes Drugs Market - By Drug class
1.3.3 Oral Anti-Diabetes Drugs Market - By Distribution channel
1.3.4 Oral Anti-Diabetes Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ORAL ANTI-DIABETES DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ORAL ANTI-DIABETES DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ORAL ANTI-DIABETES DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ORAL ANTI-DIABETES DRUGS - GLOBAL MARKET OVERVIEW
6.2. ORAL ANTI-DIABETES DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ORAL ANTI-DIABETES DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DOSAGE TYPE
7.1. OVERVIEW
7.2. DOSAGE TYPE MARKET FORECASTS AND ANALYSIS
7.3. LIQUID
7.3.1. Overview
7.3.2. Liquid Market Forecast and Analysis
7.4. CAPSULE
7.4.1. Overview
7.4.2. Capsule Market Forecast and Analysis
7.5. TABLET
7.5.1. Overview
7.5.2. Tablet Market Forecast and Analysis
8. ORAL ANTI-DIABETES DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
8.1. OVERVIEW
8.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
8.3. SULFONYLUREAS
8.3.1. Overview
8.3.2. Sulfonylureas Market Forecast and Analysis
8.4. MEGLITINIDES
8.4.1. Overview
8.4.2. Meglitinides Market Forecast and Analysis
8.5. BIGUANIDES
8.5.1. Overview
8.5.2. Biguanides Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. ORAL ANTI-DIABETES DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. ORAL ANTI-DIABETES DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Oral Anti-Diabetes Drugs Market Overview
10.1.2 North America Oral Anti-Diabetes Drugs Market Forecasts and Analysis
10.1.3 North America Oral Anti-Diabetes Drugs Market Forecasts and Analysis - By Dosage type
10.1.4 North America Oral Anti-Diabetes Drugs Market Forecasts and Analysis - By Drug class
10.1.5 North America Oral Anti-Diabetes Drugs Market Forecasts and Analysis - By Distribution channel
10.1.6 North America Oral Anti-Diabetes Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Oral Anti-Diabetes Drugs Market
10.1.6.1.1 United States Oral Anti-Diabetes Drugs Market by Dosage type
10.1.6.1.2 United States Oral Anti-Diabetes Drugs Market by Drug class
10.1.6.1.3 United States Oral Anti-Diabetes Drugs Market by Distribution channel
10.1.6.2 Canada Oral Anti-Diabetes Drugs Market
10.1.6.2.1 Canada Oral Anti-Diabetes Drugs Market by Dosage type
10.1.6.2.2 Canada Oral Anti-Diabetes Drugs Market by Drug class
10.1.6.2.3 Canada Oral Anti-Diabetes Drugs Market by Distribution channel
10.1.6.3 Mexico Oral Anti-Diabetes Drugs Market
10.1.6.3.1 Mexico Oral Anti-Diabetes Drugs Market by Dosage type
10.1.6.3.2 Mexico Oral Anti-Diabetes Drugs Market by Drug class
10.1.6.3.3 Mexico Oral Anti-Diabetes Drugs Market by Distribution channel
10.2. EUROPE
10.2.1 Europe Oral Anti-Diabetes Drugs Market Overview
10.2.2 Europe Oral Anti-Diabetes Drugs Market Forecasts and Analysis
10.2.3 Europe Oral Anti-Diabetes Drugs Market Forecasts and Analysis - By Dosage type
10.2.4 Europe Oral Anti-Diabetes Drugs Market Forecasts and Analysis - By Drug class
10.2.5 Europe Oral Anti-Diabetes Drugs Market Forecasts and Analysis - By Distribution channel
10.2.6 Europe Oral Anti-Diabetes Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Oral Anti-Diabetes Drugs Market
10.2.6.1.1 Germany Oral Anti-Diabetes Drugs Market by Dosage type
10.2.6.1.2 Germany Oral Anti-Diabetes Drugs Market by Drug class
10.2.6.1.3 Germany Oral Anti-Diabetes Drugs Market by Distribution channel
10.2.6.2 France Oral Anti-Diabetes Drugs Market
10.2.6.2.1 France Oral Anti-Diabetes Drugs Market by Dosage type
10.2.6.2.2 France Oral Anti-Diabetes Drugs Market by Drug class
10.2.6.2.3 France Oral Anti-Diabetes Drugs Market by Distribution channel
10.2.6.3 Italy Oral Anti-Diabetes Drugs Market
10.2.6.3.1 Italy Oral Anti-Diabetes Drugs Market by Dosage type
10.2.6.3.2 Italy Oral Anti-Diabetes Drugs Market by Drug class
10.2.6.3.3 Italy Oral Anti-Diabetes Drugs Market by Distribution channel
10.2.6.4 Spain Oral Anti-Diabetes Drugs Market
10.2.6.4.1 Spain Oral Anti-Diabetes Drugs Market by Dosage type
10.2.6.4.2 Spain Oral Anti-Diabetes Drugs Market by Drug class
10.2.6.4.3 Spain Oral Anti-Diabetes Drugs Market by Distribution channel
10.2.6.5 United Kingdom Oral Anti-Diabetes Drugs Market
10.2.6.5.1 United Kingdom Oral Anti-Diabetes Drugs Market by Dosage type
10.2.6.5.2 United Kingdom Oral Anti-Diabetes Drugs Market by Drug class
10.2.6.5.3 United Kingdom Oral Anti-Diabetes Drugs Market by Distribution channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Oral Anti-Diabetes Drugs Market Overview
10.3.2 Asia-Pacific Oral Anti-Diabetes Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Oral Anti-Diabetes Drugs Market Forecasts and Analysis - By Dosage type
10.3.4 Asia-Pacific Oral Anti-Diabetes Drugs Market Forecasts and Analysis - By Drug class
10.3.5 Asia-Pacific Oral Anti-Diabetes Drugs Market Forecasts and Analysis - By Distribution channel
10.3.6 Asia-Pacific Oral Anti-Diabetes Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Oral Anti-Diabetes Drugs Market
10.3.6.1.1 Australia Oral Anti-Diabetes Drugs Market by Dosage type
10.3.6.1.2 Australia Oral Anti-Diabetes Drugs Market by Drug class
10.3.6.1.3 Australia Oral Anti-Diabetes Drugs Market by Distribution channel
10.3.6.2 China Oral Anti-Diabetes Drugs Market
10.3.6.2.1 China Oral Anti-Diabetes Drugs Market by Dosage type
10.3.6.2.2 China Oral Anti-Diabetes Drugs Market by Drug class
10.3.6.2.3 China Oral Anti-Diabetes Drugs Market by Distribution channel
10.3.6.3 India Oral Anti-Diabetes Drugs Market
10.3.6.3.1 India Oral Anti-Diabetes Drugs Market by Dosage type
10.3.6.3.2 India Oral Anti-Diabetes Drugs Market by Drug class
10.3.6.3.3 India Oral Anti-Diabetes Drugs Market by Distribution channel
10.3.6.4 Japan Oral Anti-Diabetes Drugs Market
10.3.6.4.1 Japan Oral Anti-Diabetes Drugs Market by Dosage type
10.3.6.4.2 Japan Oral Anti-Diabetes Drugs Market by Drug class
10.3.6.4.3 Japan Oral Anti-Diabetes Drugs Market by Distribution channel
10.3.6.5 South Korea Oral Anti-Diabetes Drugs Market
10.3.6.5.1 South Korea Oral Anti-Diabetes Drugs Market by Dosage type
10.3.6.5.2 South Korea Oral Anti-Diabetes Drugs Market by Drug class
10.3.6.5.3 South Korea Oral Anti-Diabetes Drugs Market by Distribution channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Oral Anti-Diabetes Drugs Market Overview
10.4.2 Middle East and Africa Oral Anti-Diabetes Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Oral Anti-Diabetes Drugs Market Forecasts and Analysis - By Dosage type
10.4.4 Middle East and Africa Oral Anti-Diabetes Drugs Market Forecasts and Analysis - By Drug class
10.4.5 Middle East and Africa Oral Anti-Diabetes Drugs Market Forecasts and Analysis - By Distribution channel
10.4.6 Middle East and Africa Oral Anti-Diabetes Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Oral Anti-Diabetes Drugs Market
10.4.6.1.1 South Africa Oral Anti-Diabetes Drugs Market by Dosage type
10.4.6.1.2 South Africa Oral Anti-Diabetes Drugs Market by Drug class
10.4.6.1.3 South Africa Oral Anti-Diabetes Drugs Market by Distribution channel
10.4.6.2 Saudi Arabia Oral Anti-Diabetes Drugs Market
10.4.6.2.1 Saudi Arabia Oral Anti-Diabetes Drugs Market by Dosage type
10.4.6.2.2 Saudi Arabia Oral Anti-Diabetes Drugs Market by Drug class
10.4.6.2.3 Saudi Arabia Oral Anti-Diabetes Drugs Market by Distribution channel
10.4.6.3 U.A.E Oral Anti-Diabetes Drugs Market
10.4.6.3.1 U.A.E Oral Anti-Diabetes Drugs Market by Dosage type
10.4.6.3.2 U.A.E Oral Anti-Diabetes Drugs Market by Drug class
10.4.6.3.3 U.A.E Oral Anti-Diabetes Drugs Market by Distribution channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Oral Anti-Diabetes Drugs Market Overview
10.5.2 South and Central America Oral Anti-Diabetes Drugs Market Forecasts and Analysis
10.5.3 South and Central America Oral Anti-Diabetes Drugs Market Forecasts and Analysis - By Dosage type
10.5.4 South and Central America Oral Anti-Diabetes Drugs Market Forecasts and Analysis - By Drug class
10.5.5 South and Central America Oral Anti-Diabetes Drugs Market Forecasts and Analysis - By Distribution channel
10.5.6 South and Central America Oral Anti-Diabetes Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Oral Anti-Diabetes Drugs Market
10.5.6.1.1 Brazil Oral Anti-Diabetes Drugs Market by Dosage type
10.5.6.1.2 Brazil Oral Anti-Diabetes Drugs Market by Drug class
10.5.6.1.3 Brazil Oral Anti-Diabetes Drugs Market by Distribution channel
10.5.6.2 Argentina Oral Anti-Diabetes Drugs Market
10.5.6.2.1 Argentina Oral Anti-Diabetes Drugs Market by Dosage type
10.5.6.2.2 Argentina Oral Anti-Diabetes Drugs Market by Drug class
10.5.6.2.3 Argentina Oral Anti-Diabetes Drugs Market by Distribution channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ORAL ANTI-DIABETES DRUGS MARKET, KEY COMPANY PROFILES
12.1. ABBOTT
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BIOCON
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ELI LILLY AND COMPANY
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GLAXOSMITHKLINE PLC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK AND CO., INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. NOVARTIS AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NOVO NORDISK A/S
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PIRAMAL ENTERPRISES LTD.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SANOFI
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SUN PHARMACEUTICAL INDUSTRIES LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott
2. Biocon
3. Eli Lilly and Company
4. GlaxoSmithKline plc.
5. Merck & Co., Inc.
6. Novartis AG
7. Novo Nordisk A/S
8. Piramal Enterprises Ltd.
9. Sanofi
10. Sun Pharmaceutical Industries Ltd.

Related Tags Oral Anti-Diabetes Drugs Market Oral Anti-Diabetes Drugs Market Research Oral Anti-Diabetes Drugs Market Insight Oral Anti-Diabetes Drugs Market Trends Oral Anti-Diabetes Drugs Market Forecast Oral Anti-Diabetes Drugs Market Share Oral Anti-Diabetes Drugs Market 2027 Oral Anti-Diabetes Drugs